nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP1A2—type 2 diabetes mellitus	0.186	0.602	CbGaD
Efavirenz—CYP3A4—type 2 diabetes mellitus	0.123	0.398	CbGaD
Efavirenz—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0223	0.0468	CbGbCtD
Efavirenz—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0218	0.0457	CbGbCtD
Efavirenz—CYP2C9—Glipizide—type 2 diabetes mellitus	0.02	0.0418	CbGbCtD
Efavirenz—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.019	0.0398	CbGbCtD
Efavirenz—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.019	0.0398	CbGbCtD
Efavirenz—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0186	0.0389	CbGbCtD
Efavirenz—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0175	0.0367	CbGbCtD
Efavirenz—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0169	0.0354	CbGbCtD
Efavirenz—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0162	0.0339	CbGbCtD
Efavirenz—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0158	0.0331	CbGbCtD
Efavirenz—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0158	0.0331	CbGbCtD
Efavirenz—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0146	0.0305	CbGbCtD
Efavirenz—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0144	0.0302	CbGbCtD
Efavirenz—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0143	0.0298	CbGbCtD
Efavirenz—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0141	0.0295	CbGbCtD
Efavirenz—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0133	0.0279	CbGbCtD
Efavirenz—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0129	0.0269	CbGbCtD
Efavirenz—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0127	0.0267	CbGbCtD
Efavirenz—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0127	0.0266	CbGbCtD
Efavirenz—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.012	0.0252	CbGbCtD
Efavirenz—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.012	0.0251	CbGbCtD
Efavirenz—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0116	0.0243	CbGbCtD
Efavirenz—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0115	0.024	CbGbCtD
Efavirenz—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0109	0.0229	CbGbCtD
Efavirenz—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0105	0.022	CbGbCtD
Efavirenz—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0102	0.0213	CbGbCtD
Efavirenz—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00973	0.0204	CbGbCtD
Efavirenz—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00919	0.0192	CbGbCtD
Efavirenz—CYP2C19—Losartan—type 2 diabetes mellitus	0.0089	0.0186	CbGbCtD
Efavirenz—CYP1A2—Losartan—type 2 diabetes mellitus	0.00821	0.0172	CbGbCtD
Efavirenz—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00809	0.0169	CbGbCtD
Efavirenz—CYP2C9—Losartan—type 2 diabetes mellitus	0.0074	0.0155	CbGbCtD
Efavirenz—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00696	0.0146	CbGbCtD
Efavirenz—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00667	0.014	CbGbCtD
Efavirenz—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00667	0.014	CbGbCtD
Efavirenz—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00631	0.0132	CbGbCtD
Efavirenz—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0047	0.00984	CbGbCtD
Efavirenz—CYP3A4—Losartan—type 2 diabetes mellitus	0.0043	0.009	CbGbCtD
Efavirenz—Flushing—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000385	CcSEcCtD
Efavirenz—Angioedema—Losartan—type 2 diabetes mellitus	6.59e-05	0.000384	CcSEcCtD
Efavirenz—Insomnia—Valsartan—type 2 diabetes mellitus	6.58e-05	0.000384	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.55e-05	0.000382	CcSEcCtD
Efavirenz—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.54e-05	0.000381	CcSEcCtD
Efavirenz—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.53e-05	0.000381	CcSEcCtD
Efavirenz—Myalgia—Irbesartan—type 2 diabetes mellitus	6.53e-05	0.000381	CcSEcCtD
Efavirenz—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.53e-05	0.000381	CcSEcCtD
Efavirenz—Chest pain—Irbesartan—type 2 diabetes mellitus	6.53e-05	0.000381	CcSEcCtD
Efavirenz—Shock—Metformin—type 2 diabetes mellitus	6.52e-05	0.00038	CcSEcCtD
Efavirenz—Insomnia—Orlistat—type 2 diabetes mellitus	6.51e-05	0.00038	CcSEcCtD
Efavirenz—Malaise—Losartan—type 2 diabetes mellitus	6.51e-05	0.000379	CcSEcCtD
Efavirenz—Anxiety—Irbesartan—type 2 diabetes mellitus	6.5e-05	0.000379	CcSEcCtD
Efavirenz—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.5e-05	0.000379	CcSEcCtD
Efavirenz—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.5e-05	0.000379	CcSEcCtD
Efavirenz—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.49e-05	0.000379	CcSEcCtD
Efavirenz—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.49e-05	0.000379	CcSEcCtD
Efavirenz—Vertigo—Losartan—type 2 diabetes mellitus	6.48e-05	0.000378	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000378	CcSEcCtD
Efavirenz—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.48e-05	0.000378	CcSEcCtD
Efavirenz—Somnolence—Valsartan—type 2 diabetes mellitus	6.47e-05	0.000377	CcSEcCtD
Efavirenz—Syncope—Losartan—type 2 diabetes mellitus	6.47e-05	0.000377	CcSEcCtD
Efavirenz—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.46e-05	0.000377	CcSEcCtD
Efavirenz—Discomfort—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000376	CcSEcCtD
Efavirenz—Skin disorder—Metformin—type 2 diabetes mellitus	6.44e-05	0.000376	CcSEcCtD
Efavirenz—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000374	CcSEcCtD
Efavirenz—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.41e-05	0.000374	CcSEcCtD
Efavirenz—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.41e-05	0.000374	CcSEcCtD
Efavirenz—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000374	CcSEcCtD
Efavirenz—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.38e-05	0.000372	CcSEcCtD
Efavirenz—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000372	CcSEcCtD
Efavirenz—Palpitations—Losartan—type 2 diabetes mellitus	6.37e-05	0.000372	CcSEcCtD
Efavirenz—Nausea—Glimepiride—type 2 diabetes mellitus	6.36e-05	0.000371	CcSEcCtD
Efavirenz—Arrhythmia—Ramipril—type 2 diabetes mellitus	6.35e-05	0.00037	CcSEcCtD
Efavirenz—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.34e-05	0.00037	CcSEcCtD
Efavirenz—Nausea—Sitagliptin—type 2 diabetes mellitus	6.34e-05	0.00037	CcSEcCtD
Efavirenz—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.33e-05	0.000369	CcSEcCtD
Efavirenz—Asthenia—Glyburide—type 2 diabetes mellitus	6.33e-05	0.000369	CcSEcCtD
Efavirenz—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.33e-05	0.000369	CcSEcCtD
Efavirenz—Anorexia—Metformin—type 2 diabetes mellitus	6.32e-05	0.000369	CcSEcCtD
Efavirenz—Cough—Losartan—type 2 diabetes mellitus	6.29e-05	0.000367	CcSEcCtD
Efavirenz—Urticaria—Gliclazide—type 2 diabetes mellitus	6.29e-05	0.000367	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000367	CcSEcCtD
Efavirenz—Alopecia—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000366	CcSEcCtD
Efavirenz—Fatigue—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000366	CcSEcCtD
Efavirenz—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.26e-05	0.000365	CcSEcCtD
Efavirenz—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.26e-05	0.000365	CcSEcCtD
Efavirenz—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.25e-05	0.000365	CcSEcCtD
Efavirenz—Pruritus—Glyburide—type 2 diabetes mellitus	6.24e-05	0.000364	CcSEcCtD
Efavirenz—Constipation—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000363	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.21e-05	0.000362	CcSEcCtD
Efavirenz—Fatigue—Orlistat—type 2 diabetes mellitus	6.2e-05	0.000362	CcSEcCtD
Efavirenz—Malnutrition—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000361	CcSEcCtD
Efavirenz—Erythema—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000361	CcSEcCtD
Efavirenz—Shock—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000359	CcSEcCtD
Efavirenz—Pain—Orlistat—type 2 diabetes mellitus	6.15e-05	0.000359	CcSEcCtD
Efavirenz—Chest pain—Losartan—type 2 diabetes mellitus	6.14e-05	0.000358	CcSEcCtD
Efavirenz—Arthralgia—Losartan—type 2 diabetes mellitus	6.14e-05	0.000358	CcSEcCtD
Efavirenz—Myalgia—Losartan—type 2 diabetes mellitus	6.14e-05	0.000358	CcSEcCtD
Efavirenz—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.14e-05	0.000358	CcSEcCtD
Efavirenz—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.14e-05	0.000358	CcSEcCtD
Efavirenz—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.13e-05	0.000357	CcSEcCtD
Efavirenz—Anxiety—Losartan—type 2 diabetes mellitus	6.12e-05	0.000357	CcSEcCtD
Efavirenz—Tachycardia—Irbesartan—type 2 diabetes mellitus	6.11e-05	0.000356	CcSEcCtD
Efavirenz—Rash—Bromocriptine—type 2 diabetes mellitus	6.09e-05	0.000355	CcSEcCtD
Efavirenz—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.08e-05	0.000355	CcSEcCtD
Efavirenz—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.08e-05	0.000354	CcSEcCtD
Efavirenz—Tension—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000354	CcSEcCtD
Efavirenz—Discomfort—Losartan—type 2 diabetes mellitus	6.07e-05	0.000354	CcSEcCtD
Efavirenz—Dysgeusia—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000353	CcSEcCtD
Efavirenz—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.05e-05	0.000353	CcSEcCtD
Efavirenz—Headache—Bromocriptine—type 2 diabetes mellitus	6.05e-05	0.000353	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.04e-05	0.000352	CcSEcCtD
Efavirenz—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.04e-05	0.000352	CcSEcCtD
Efavirenz—Nervousness—Ramipril—type 2 diabetes mellitus	6.01e-05	0.00035	CcSEcCtD
Efavirenz—Dry mouth—Losartan—type 2 diabetes mellitus	6.01e-05	0.00035	CcSEcCtD
Efavirenz—Anorexia—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000348	CcSEcCtD
Efavirenz—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.95e-05	0.000347	CcSEcCtD
Efavirenz—Paraesthesia—Metformin—type 2 diabetes mellitus	5.95e-05	0.000347	CcSEcCtD
Efavirenz—Confusional state—Losartan—type 2 diabetes mellitus	5.94e-05	0.000346	CcSEcCtD
Efavirenz—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.93e-05	0.000346	CcSEcCtD
Efavirenz—Dyspnoea—Metformin—type 2 diabetes mellitus	5.91e-05	0.000345	CcSEcCtD
Efavirenz—Somnolence—Metformin—type 2 diabetes mellitus	5.89e-05	0.000344	CcSEcCtD
Efavirenz—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.88e-05	0.000343	CcSEcCtD
Efavirenz—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.84e-05	0.000341	CcSEcCtD
Efavirenz—Dyspepsia—Metformin—type 2 diabetes mellitus	5.84e-05	0.00034	CcSEcCtD
Efavirenz—Tremor—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000338	CcSEcCtD
Efavirenz—Shock—Losartan—type 2 diabetes mellitus	5.79e-05	0.000338	CcSEcCtD
Efavirenz—Urticaria—Valsartan—type 2 diabetes mellitus	5.78e-05	0.000337	CcSEcCtD
Efavirenz—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.77e-05	0.000337	CcSEcCtD
Efavirenz—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.76e-05	0.000336	CcSEcCtD
Efavirenz—Decreased appetite—Metformin—type 2 diabetes mellitus	5.76e-05	0.000336	CcSEcCtD
Efavirenz—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.75e-05	0.000336	CcSEcCtD
Efavirenz—Tachycardia—Losartan—type 2 diabetes mellitus	5.75e-05	0.000335	CcSEcCtD
Efavirenz—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000335	CcSEcCtD
Efavirenz—Nausea—Bromocriptine—type 2 diabetes mellitus	5.73e-05	0.000334	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.72e-05	0.000334	CcSEcCtD
Efavirenz—Fatigue—Metformin—type 2 diabetes mellitus	5.72e-05	0.000333	CcSEcCtD
Efavirenz—Urticaria—Orlistat—type 2 diabetes mellitus	5.71e-05	0.000333	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.000332	CcSEcCtD
Efavirenz—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.69e-05	0.000332	CcSEcCtD
Efavirenz—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.69e-05	0.000332	CcSEcCtD
Efavirenz—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.69e-05	0.000332	CcSEcCtD
Efavirenz—Asthenia—Gliclazide—type 2 diabetes mellitus	5.68e-05	0.000332	CcSEcCtD
Efavirenz—Agitation—Ramipril—type 2 diabetes mellitus	5.68e-05	0.000332	CcSEcCtD
Efavirenz—Constipation—Metformin—type 2 diabetes mellitus	5.67e-05	0.000331	CcSEcCtD
Efavirenz—Angioedema—Ramipril—type 2 diabetes mellitus	5.65e-05	0.00033	CcSEcCtD
Efavirenz—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.62e-05	0.000328	CcSEcCtD
Efavirenz—Anorexia—Losartan—type 2 diabetes mellitus	5.61e-05	0.000327	CcSEcCtD
Efavirenz—Vomiting—Glyburide—type 2 diabetes mellitus	5.61e-05	0.000327	CcSEcCtD
Efavirenz—Pruritus—Gliclazide—type 2 diabetes mellitus	5.61e-05	0.000327	CcSEcCtD
Efavirenz—Malaise—Ramipril—type 2 diabetes mellitus	5.58e-05	0.000325	CcSEcCtD
Efavirenz—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000325	CcSEcCtD
Efavirenz—Rash—Glyburide—type 2 diabetes mellitus	5.56e-05	0.000325	CcSEcCtD
Efavirenz—Somnolence—Irbesartan—type 2 diabetes mellitus	5.56e-05	0.000324	CcSEcCtD
Efavirenz—Dermatitis—Glyburide—type 2 diabetes mellitus	5.56e-05	0.000324	CcSEcCtD
Efavirenz—Vertigo—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000324	CcSEcCtD
Efavirenz—Syncope—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000324	CcSEcCtD
Efavirenz—Headache—Glyburide—type 2 diabetes mellitus	5.53e-05	0.000322	CcSEcCtD
Efavirenz—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000321	CcSEcCtD
Efavirenz—Palpitations—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000319	CcSEcCtD
Efavirenz—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.46e-05	0.000319	CcSEcCtD
Efavirenz—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000317	CcSEcCtD
Efavirenz—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000317	CcSEcCtD
Efavirenz—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.42e-05	0.000316	CcSEcCtD
Efavirenz—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.42e-05	0.000316	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000315	CcSEcCtD
Efavirenz—Cough—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000315	CcSEcCtD
Efavirenz—Fatigue—Irbesartan—type 2 diabetes mellitus	5.39e-05	0.000315	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.36e-05	0.000313	CcSEcCtD
Efavirenz—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.36e-05	0.000313	CcSEcCtD
Efavirenz—Convulsion—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000313	CcSEcCtD
Efavirenz—Pain—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000312	CcSEcCtD
Efavirenz—Constipation—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000312	CcSEcCtD
Efavirenz—Insomnia—Losartan—type 2 diabetes mellitus	5.32e-05	0.000311	CcSEcCtD
Efavirenz—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.3e-05	0.000309	CcSEcCtD
Efavirenz—Paraesthesia—Losartan—type 2 diabetes mellitus	5.29e-05	0.000308	CcSEcCtD
Efavirenz—Urticaria—Metformin—type 2 diabetes mellitus	5.27e-05	0.000307	CcSEcCtD
Efavirenz—Myalgia—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000307	CcSEcCtD
Efavirenz—Chest pain—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000307	CcSEcCtD
Efavirenz—Arthralgia—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000307	CcSEcCtD
Efavirenz—Dyspnoea—Losartan—type 2 diabetes mellitus	5.25e-05	0.000306	CcSEcCtD
Efavirenz—Anxiety—Ramipril—type 2 diabetes mellitus	5.25e-05	0.000306	CcSEcCtD
Efavirenz—Nausea—Glyburide—type 2 diabetes mellitus	5.24e-05	0.000306	CcSEcCtD
Efavirenz—Abdominal pain—Metformin—type 2 diabetes mellitus	5.24e-05	0.000306	CcSEcCtD
Efavirenz—Dizziness—Gliclazide—type 2 diabetes mellitus	5.24e-05	0.000306	CcSEcCtD
Efavirenz—Somnolence—Losartan—type 2 diabetes mellitus	5.23e-05	0.000305	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000305	CcSEcCtD
Efavirenz—Asthenia—Valsartan—type 2 diabetes mellitus	5.22e-05	0.000305	CcSEcCtD
Efavirenz—Discomfort—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000304	CcSEcCtD
Efavirenz—Dyspepsia—Losartan—type 2 diabetes mellitus	5.18e-05	0.000302	CcSEcCtD
Efavirenz—Asthenia—Orlistat—type 2 diabetes mellitus	5.16e-05	0.000301	CcSEcCtD
Efavirenz—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000301	CcSEcCtD
Efavirenz—Pruritus—Valsartan—type 2 diabetes mellitus	5.15e-05	0.0003	CcSEcCtD
Efavirenz—Dry mouth—Ramipril—type 2 diabetes mellitus	5.15e-05	0.0003	CcSEcCtD
Efavirenz—Decreased appetite—Losartan—type 2 diabetes mellitus	5.12e-05	0.000299	CcSEcCtD
Efavirenz—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.000298	CcSEcCtD
Efavirenz—Confusional state—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000297	CcSEcCtD
Efavirenz—Pruritus—Orlistat—type 2 diabetes mellitus	5.09e-05	0.000297	CcSEcCtD
Efavirenz—Fatigue—Losartan—type 2 diabetes mellitus	5.08e-05	0.000296	CcSEcCtD
Efavirenz—Vomiting—Gliclazide—type 2 diabetes mellitus	5.04e-05	0.000294	CcSEcCtD
Efavirenz—Pain—Losartan—type 2 diabetes mellitus	5.03e-05	0.000294	CcSEcCtD
Efavirenz—Constipation—Losartan—type 2 diabetes mellitus	5.03e-05	0.000294	CcSEcCtD
Efavirenz—Rash—Gliclazide—type 2 diabetes mellitus	5e-05	0.000291	CcSEcCtD
Efavirenz—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.99e-05	0.000291	CcSEcCtD
Efavirenz—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.98e-05	0.000291	CcSEcCtD
Efavirenz—Urticaria—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.00029	CcSEcCtD
Efavirenz—Shock—Ramipril—type 2 diabetes mellitus	4.97e-05	0.00029	CcSEcCtD
Efavirenz—Headache—Gliclazide—type 2 diabetes mellitus	4.96e-05	0.00029	CcSEcCtD
Efavirenz—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000289	CcSEcCtD
Efavirenz—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000288	CcSEcCtD
Efavirenz—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000288	CcSEcCtD
Efavirenz—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000288	CcSEcCtD
Efavirenz—Tachycardia—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000287	CcSEcCtD
Efavirenz—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.92e-05	0.000287	CcSEcCtD
Efavirenz—Skin disorder—Ramipril—type 2 diabetes mellitus	4.9e-05	0.000286	CcSEcCtD
Efavirenz—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000285	CcSEcCtD
Efavirenz—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.85e-05	0.000283	CcSEcCtD
Efavirenz—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.81e-05	0.000281	CcSEcCtD
Efavirenz—Dizziness—Valsartan—type 2 diabetes mellitus	4.81e-05	0.000281	CcSEcCtD
Efavirenz—Anorexia—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000281	CcSEcCtD
Efavirenz—Dizziness—Orlistat—type 2 diabetes mellitus	4.76e-05	0.000277	CcSEcCtD
Efavirenz—Asthenia—Metformin—type 2 diabetes mellitus	4.76e-05	0.000277	CcSEcCtD
Efavirenz—Nausea—Gliclazide—type 2 diabetes mellitus	4.71e-05	0.000275	CcSEcCtD
Efavirenz—Pruritus—Metformin—type 2 diabetes mellitus	4.69e-05	0.000274	CcSEcCtD
Efavirenz—Urticaria—Losartan—type 2 diabetes mellitus	4.68e-05	0.000273	CcSEcCtD
Efavirenz—Abdominal pain—Losartan—type 2 diabetes mellitus	4.65e-05	0.000271	CcSEcCtD
Efavirenz—Body temperature increased—Losartan—type 2 diabetes mellitus	4.65e-05	0.000271	CcSEcCtD
Efavirenz—Vomiting—Valsartan—type 2 diabetes mellitus	4.63e-05	0.00027	CcSEcCtD
Efavirenz—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.61e-05	0.000269	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000268	CcSEcCtD
Efavirenz—Rash—Valsartan—type 2 diabetes mellitus	4.59e-05	0.000268	CcSEcCtD
Efavirenz—Dermatitis—Valsartan—type 2 diabetes mellitus	4.59e-05	0.000267	CcSEcCtD
Efavirenz—Vomiting—Orlistat—type 2 diabetes mellitus	4.57e-05	0.000267	CcSEcCtD
Efavirenz—Insomnia—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000266	CcSEcCtD
Efavirenz—Headache—Valsartan—type 2 diabetes mellitus	4.56e-05	0.000266	CcSEcCtD
Efavirenz—Diarrhoea—Metformin—type 2 diabetes mellitus	4.54e-05	0.000265	CcSEcCtD
Efavirenz—Rash—Orlistat—type 2 diabetes mellitus	4.54e-05	0.000265	CcSEcCtD
Efavirenz—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000264	CcSEcCtD
Efavirenz—Dermatitis—Orlistat—type 2 diabetes mellitus	4.53e-05	0.000264	CcSEcCtD
Efavirenz—Headache—Orlistat—type 2 diabetes mellitus	4.51e-05	0.000263	CcSEcCtD
Efavirenz—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000263	CcSEcCtD
Efavirenz—Asthenia—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000262	CcSEcCtD
Efavirenz—Somnolence—Ramipril—type 2 diabetes mellitus	4.49e-05	0.000262	CcSEcCtD
Efavirenz—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000259	CcSEcCtD
Efavirenz—Pruritus—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000258	CcSEcCtD
Efavirenz—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000256	CcSEcCtD
Efavirenz—Dizziness—Metformin—type 2 diabetes mellitus	4.38e-05	0.000256	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000254	CcSEcCtD
Efavirenz—Fatigue—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000254	CcSEcCtD
Efavirenz—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.34e-05	0.000253	CcSEcCtD
Efavirenz—Nausea—Valsartan—type 2 diabetes mellitus	4.32e-05	0.000252	CcSEcCtD
Efavirenz—Constipation—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000252	CcSEcCtD
Efavirenz—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.00025	CcSEcCtD
Efavirenz—Nausea—Orlistat—type 2 diabetes mellitus	4.27e-05	0.000249	CcSEcCtD
Efavirenz—Asthenia—Losartan—type 2 diabetes mellitus	4.22e-05	0.000246	CcSEcCtD
Efavirenz—Vomiting—Metformin—type 2 diabetes mellitus	4.21e-05	0.000246	CcSEcCtD
Efavirenz—Rash—Metformin—type 2 diabetes mellitus	4.18e-05	0.000244	CcSEcCtD
Efavirenz—Dermatitis—Metformin—type 2 diabetes mellitus	4.18e-05	0.000244	CcSEcCtD
Efavirenz—Pruritus—Losartan—type 2 diabetes mellitus	4.17e-05	0.000243	CcSEcCtD
Efavirenz—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000243	CcSEcCtD
Efavirenz—Headache—Metformin—type 2 diabetes mellitus	4.15e-05	0.000242	CcSEcCtD
Efavirenz—Dizziness—Irbesartan—type 2 diabetes mellitus	4.14e-05	0.000241	CcSEcCtD
Efavirenz—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000241	CcSEcCtD
Efavirenz—Diarrhoea—Losartan—type 2 diabetes mellitus	4.03e-05	0.000235	CcSEcCtD
Efavirenz—Urticaria—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000234	CcSEcCtD
Efavirenz—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000233	CcSEcCtD
Efavirenz—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000233	CcSEcCtD
Efavirenz—Vomiting—Irbesartan—type 2 diabetes mellitus	3.98e-05	0.000232	CcSEcCtD
Efavirenz—Rash—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.00023	CcSEcCtD
Efavirenz—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.00023	CcSEcCtD
Efavirenz—Nausea—Metformin—type 2 diabetes mellitus	3.94e-05	0.00023	CcSEcCtD
Efavirenz—Headache—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000229	CcSEcCtD
Efavirenz—Dizziness—Losartan—type 2 diabetes mellitus	3.89e-05	0.000227	CcSEcCtD
Efavirenz—Vomiting—Losartan—type 2 diabetes mellitus	3.74e-05	0.000218	CcSEcCtD
Efavirenz—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000217	CcSEcCtD
Efavirenz—Nausea—Irbesartan—type 2 diabetes mellitus	3.72e-05	0.000217	CcSEcCtD
Efavirenz—Rash—Losartan—type 2 diabetes mellitus	3.71e-05	0.000217	CcSEcCtD
Efavirenz—Dermatitis—Losartan—type 2 diabetes mellitus	3.71e-05	0.000216	CcSEcCtD
Efavirenz—Headache—Losartan—type 2 diabetes mellitus	3.69e-05	0.000215	CcSEcCtD
Efavirenz—Asthenia—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000211	CcSEcCtD
Efavirenz—Pruritus—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000208	CcSEcCtD
Efavirenz—Nausea—Losartan—type 2 diabetes mellitus	3.5e-05	0.000204	CcSEcCtD
Efavirenz—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000201	CcSEcCtD
Efavirenz—Dizziness—Ramipril—type 2 diabetes mellitus	3.34e-05	0.000195	CcSEcCtD
Efavirenz—Vomiting—Ramipril—type 2 diabetes mellitus	3.21e-05	0.000187	CcSEcCtD
Efavirenz—Rash—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000186	CcSEcCtD
Efavirenz—Dermatitis—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000185	CcSEcCtD
Efavirenz—Headache—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000184	CcSEcCtD
Efavirenz—Nausea—Ramipril—type 2 diabetes mellitus	3e-05	0.000175	CcSEcCtD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.37e-06	0.000155	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.36e-06	0.000155	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	6.35e-06	0.000155	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	6.35e-06	0.000155	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	6.35e-06	0.000155	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.34e-06	0.000155	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.3e-06	0.000154	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.3e-06	0.000154	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.3e-06	0.000154	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	6.3e-06	0.000154	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.28e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.28e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	6.28e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.26e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	6.25e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	6.23e-06	0.000152	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.23e-06	0.000152	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.19e-06	0.000151	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	6.18e-06	0.000151	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	6.17e-06	0.000151	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.09e-06	0.000149	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	6.04e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	5.99e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.93e-06	0.000145	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.84e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.84e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.84e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	5.82e-06	0.000142	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	5.81e-06	0.000142	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.81e-06	0.000142	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.79e-06	0.000141	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.79e-06	0.000141	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.79e-06	0.000141	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.78e-06	0.000141	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	5.74e-06	0.00014	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	5.74e-06	0.00014	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.73e-06	0.00014	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	5.72e-06	0.00014	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.68e-06	0.000139	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.68e-06	0.000139	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.66e-06	0.000138	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.66e-06	0.000138	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.63e-06	0.000138	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	5.6e-06	0.000137	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	5.6e-06	0.000137	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	5.58e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.57e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.56e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.55e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.55e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.55e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.52e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.52e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.52e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.52e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.51e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	5.51e-06	0.000134	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	5.51e-06	0.000134	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.48e-06	0.000134	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	5.43e-06	0.000133	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.38e-06	0.000131	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.36e-06	0.000131	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.36e-06	0.000131	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.36e-06	0.000131	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.36e-06	0.000131	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.36e-06	0.000131	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.34e-06	0.00013	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.32e-06	0.00013	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.3e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.28e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.28e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.24e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.24e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.15e-06	0.000126	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	5.15e-06	0.000126	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.14e-06	0.000125	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.11e-06	0.000125	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.08e-06	0.000124	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.06e-06	0.000124	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.06e-06	0.000124	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	5.05e-06	0.000123	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.02e-06	0.000123	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.02e-06	0.000123	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.96e-06	0.000121	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.95e-06	0.000121	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.95e-06	0.000121	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.95e-06	0.000121	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	4.89e-06	0.000119	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.86e-06	0.000119	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.81e-06	0.000118	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.81e-06	0.000117	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.79e-06	0.000117	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.78e-06	0.000117	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.75e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.75e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.75e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.74e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.72e-06	0.000115	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.71e-06	0.000115	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.66e-06	0.000114	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.53e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.52e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.47e-06	0.000109	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.46e-06	0.000109	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.4e-06	0.000107	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.37e-06	0.000107	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.37e-06	0.000107	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.36e-06	0.000107	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.36e-06	0.000107	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.36e-06	0.000107	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.34e-06	0.000106	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.34e-06	0.000106	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.33e-06	0.000106	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.33e-06	0.000106	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.32e-06	0.000105	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.31e-06	0.000105	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.29e-06	0.000105	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.29e-06	0.000105	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.29e-06	0.000105	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.28e-06	0.000105	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.26e-06	0.000104	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.26e-06	0.000104	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.26e-06	0.000104	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.25e-06	0.000104	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.23e-06	0.000103	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.23e-06	0.000103	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.21e-06	0.000103	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	4.17e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.16e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.16e-06	0.000101	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.13e-06	0.000101	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.11e-06	0.0001	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	4.1e-06	0.0001	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	4.09e-06	0.0001	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	4.05e-06	9.9e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.05e-06	9.88e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.01e-06	9.8e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.97e-06	9.7e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.94e-06	9.62e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.89e-06	9.5e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.89e-06	9.5e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.88e-06	9.47e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.86e-06	9.42e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.84e-06	9.38e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.82e-06	9.32e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.82e-06	9.32e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.82e-06	9.32e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.82e-06	9.32e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.78e-06	9.22e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.75e-06	9.16e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.75e-06	9.15e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.74e-06	9.14e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.73e-06	9.1e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.71e-06	9.07e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.7e-06	9.03e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.7e-06	9.03e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.7e-06	9.02e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.7e-06	9.02e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.68e-06	8.99e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.63e-06	8.88e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.63e-06	8.87e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.63e-06	8.87e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.62e-06	8.84e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.59e-06	8.77e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.59e-06	8.77e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.58e-06	8.74e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.58e-06	8.74e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.55e-06	8.66e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.53e-06	8.61e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.51e-06	8.57e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.49e-06	8.53e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.48e-06	8.5e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.45e-06	8.43e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.45e-06	8.43e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.43e-06	8.37e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.4e-06	8.3e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.37e-06	8.23e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.37e-06	8.22e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.34e-06	8.16e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.33e-06	8.13e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.31e-06	8.09e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.31e-06	8.08e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.31e-06	8.08e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.3e-06	8.06e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.3e-06	8.05e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.29e-06	8.04e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.28e-06	8.02e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	3.28e-06	8.02e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.26e-06	7.97e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.2e-06	7.81e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.16e-06	7.71e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.15e-06	7.7e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.09e-06	7.55e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.03e-06	7.4e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.97e-06	7.26e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.9e-06	7.08e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.88e-06	7.03e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.88e-06	7.02e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.85e-06	6.97e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.85e-06	6.97e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.85e-06	6.95e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.84e-06	6.94e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.84e-06	6.92e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.83e-06	6.91e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.82e-06	6.89e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.82e-06	6.89e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.8e-06	6.84e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.79e-06	6.81e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.72e-06	6.64e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.71e-06	6.62e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.71e-06	6.62e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.65e-06	6.46e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.61e-06	6.37e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.6e-06	6.34e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.59e-06	6.31e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.54e-06	6.21e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.53e-06	6.19e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.5e-06	6.09e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.5e-06	6.09e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.48e-06	6.06e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.47e-06	6.04e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.47e-06	6.04e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.47e-06	6.03e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.46e-06	6e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.44e-06	5.95e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.41e-06	5.89e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.34e-06	5.71e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.29e-06	5.6e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.28e-06	5.57e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.26e-06	5.52e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.22e-06	5.43e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.21e-06	5.4e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.19e-06	5.34e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.18e-06	5.32e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.15e-06	5.26e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.11e-06	5.16e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.11e-06	5.16e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.93e-06	4.72e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.9e-06	4.63e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.86e-06	4.54e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.71e-06	4.16e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.65e-06	4.03e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.63e-06	3.98e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.63e-06	3.98e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.49e-06	3.64e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.25e-06	3.04e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.15e-06	2.8e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.14e-06	2.78e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	9.72e-07	2.37e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.5e-07	1.83e-05	CbGpPWpGaD
